Antioxidants: Friend or foe for tuberculosis patients

  • Bhattacharyya R
  • Banerjee D
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Respiratory burst induced bacteria killing by oxidants are important mechanism of host defence. However, it is impaired in tuberculosis due to inhibition of respiratory burst by Mycobacterial factors. Antioxidants are compounds that cause chelation of reactive oxygen species. So, antioxidants are expected to play a negative role in the management of active tuberculosis. But, oxidative stress is a proved fact that invariably happens in tuberculosis patients which is known to cause immunosuppression. Immunosuppression in turn is expected to augment tuberculosis. Hence, antioxidant supplementation is expected to benefit tuberculosis patients by minimising oxidative stress induced immunosuppression. Therefore, the role of antioxidants in tuberculosis appears to be paradoxical and urgent understanding of the role of antioxidant supplementation in tuberculosis is warranted. It is in this context that we have reviewed the recent literature and addressed the problem for its solution.

Cite

CITATION STYLE

APA

Bhattacharyya, R., & Banerjee, D. (2013). Antioxidants: Friend or foe for tuberculosis patients. Advances in Bioscience and Biotechnology, 04(11), 10–14. https://doi.org/10.4236/abb.2013.411a2002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free